Works by MIKU ANZAI
Results: 4
Evaluation of Cardiac Adverse Events with Nivolumab Using a Japanese Real-World Database.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 3, p. 177, doi. 10.1007/s40261-023-01246-x
- By:
- Publication type:
- Article
Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-35602-w
- By:
- Publication type:
- Article
Evaluation of Time to Onset and Outcome of Lung Adverse Events Related to Pembrolizumab Using Marketing Surveillance.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 817, doi. 10.1159/000533302
- By:
- Publication type:
- Article
Evaluation of Times-to-onset and Outcomes of Lung Adverse Events Associated With Sorafenib Using JADER.
- Published in:
- In Vivo, 2025, v. 39, n. 1, p. 360, doi. 10.21873/invivo.13836
- By:
- Publication type:
- Article